Article
Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
Scientific reports - 7 Mar 2017
Qiu Qi, Huang Jing, Shu Xiaoming, Fan Huizheng, Zhou Youwen, Xiao Cheng
Abstract excerpt
Methotrexate (MTX) is widely used and considered a first-line disease modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Many of the relevant genes have been investigated to estimate the association between gene polymorphisms and MTX effectiveness in RA patients, although inconsistent results have been reported. A systematic review and meta-analysis were performed to identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
